EncephalApp Stroop测试用于在突尼斯肝硬化患者中进行隐蔽肝脏脑病查
Lamine Hamzaoui1, Moufida Mahmoudi1, Ghanem Mohamed2
1Gastroenterology, Mohamed Taher Maamouri Hospital, Tunis El Manar University, Faculty of Medicine of Tunis, Nabeul, Tunisia.
F1000Research
|September 28, 2023
概括
隐性肝脑病变 (CHE) 影响了近四分之一的突尼斯肝硬化患者. EncephalApp Stroop测试有效地选这种情况,有助于早期检测肝脏疾病管理.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 神经学 神经学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 隐藏性肝脑病变 (CHE) 由于表现微妙,因此经常被诊断不足.
- EncephalApp Stroop测试提供了一个验证的CHE查方法.
研究的目的:
- 建立突尼斯标准用于使用健康对照的EncephalAppStroop测试.
- 确定突尼斯肝硬化患者中CHE的患病率.
主要方法:
- 一项前性,多中心,横截面研究,涉及142名肝硬化患者和40岁以上的健康对照.
- 使用了简化EncephalAppStroop测试的阿拉伯版本,其中包含"开启"和"关闭"的刺激组件.
- 根据EncephalApp Stroop测试结果和临床诊断评估的流行率.
主要成果:
- 突尼斯肝硬化患者中CHE的患病率为28.17% (或包括明显病例在内的24.39%).
- CHE在女性和6至13年教育程度的患者中更为普遍.
- 斯特鲁普测试的响应时间与年龄呈正相关性,这表明随着年龄的增长,表现变慢.
结论:
- EncephalApp Stroop测试是一种有效的工具,用于查突尼斯肝硬化患者的CHE.
- 该研究为突尼斯人口的EncephalApp Stroop测试提供了必要的规范性数据.
更多相关视频
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
3.0K
08:54Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
314
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
